SXI Life Sciences
7.533,66
PKT
+51,91
PKT
+0,69
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.01.18 | Novartis Hold | S&P Capital IQ | |
| 25.01.18 | Novartis Underweight | Barclays Capital | |
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 24.01.18 | Novartis Neutral | Credit Suisse Group | |
| 25.01.18 | Novartis Underperform | Credit Suisse Group | |
| 24.01.18 | Novartis buy | Kepler Cheuvreux | |
| 24.01.18 | Novartis Outperform | Bernstein Research | |
| 23.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.01.18 | Novartis overweight | Morgan Stanley | |
| 18.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.01.18 | Roche Hold | Kepler Cheuvreux | |
| 17.01.18 | Roche Hold | Deutsche Bank AG | |
| 15.01.18 | Roche Neutral | UBS AG | |
| 15.01.18 | Novartis Neutral | UBS AG | |
| 15.01.18 | Roche Hold | Deutsche Bank AG | |
| 15.01.18 | Roche Sell | Société Générale Group S.A. (SG) | |
| 15.01.18 | Novartis Hold | Deutsche Bank AG | |
| 11.01.18 | Roche overweight | JP Morgan Chase & Co. | |
| 10.01.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.18 | Roche Neutral | UBS AG | |
| 05.01.18 | Roche buy | Jefferies & Company Inc. | |
| 29.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 29.12.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 27.12.17 | Novartis Halten | Norddeutsche Landesbank (Nord/LB) | |
| 27.12.17 | Roche kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 21.12.17 | Roche overweight | Barclays Capital | |
| 13.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.12.17 | Roche Hold | Deutsche Bank AG | |
| 12.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 08.12.17 | Roche Neutral | UBS AG | |
| 08.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.17 | Roche Neutral | UBS AG | |
| 07.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.12.17 | Roche Neutral | UBS AG | |
| 06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novartis Underperform | Merrill Lynch & Co., Inc. | |
| 01.12.17 | Roche Equal-Weight | Morgan Stanley |